Targeted Chemotherapy, Crizotinib, or Placebo in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer after surgery
Can targeted chemotherapy, Crizotinib, stop the growth of tumor cells by blocking the a protein from working?
ALK Gene RearrangementALK Gene TranslocationALK PositiveStage IB Non-Small Cell Lung Carcinoma AJCC v7Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7CarcinomaLung NeoplasmsCarcinoma, Non-Small-Cell LungCrizotinibClinical ObservationLaboratory Biomarker Analysis
Lead Scientists at UC Cancer
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- Tianhong Li (ucdavis)
- accepting new patients
- Start Date
- ECOG-ACRIN Cancer Research Group
- Phase 3
- Study Type
- Last Updated